Taisho Pharmaceutical Holdings is a major Japanese pharmaceutical company, not a CDMO. The company operates across domestic self-medication (OTC products including the well-known Pabron cold medicine brand), international business, and prescription pharmaceutical operations. They have multiple production facilities in Japan and FDA-registered sites. With 10 clinical trials and therapeutic focus areas in nephrology and oncology, Taisho is an integrated pharma company manufacturing its own branded products, not offering contract manufacturing services.
OTC pharmaceuticals, self-medication products, prescription drugs
1 site worldwide
Involvement in 10 clinical trials
No reviews available yet.
No documents available.